Recommendations for stroke in 2010: a challenging agenda
- Clinical Benefit of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation. Andrade, Ambar; Li, Juan; Radford, Martha; Nilasena, David; Gage, Brian // JGIM: Journal of General Internal Medicine;Jun2015, Vol. 30 Issue 6, p777
BACKGROUND: Guidelines for anticoagulant therapy in patients with atrial fibrillation (AF) conflict with each other. The American College of Chest Physicians (ACCP) guidelines suggest no anticoagulant therapy for patients with a CHADS score of 0. The European Society of Cardiology (ESC) prefer...
- Atrial fibrillation: Physicians sit on the fence. // Patient Care;1/30/1999, Vol. 32 Issue 2, p12
Cites the results of a survey showing pharmacologic means by which physicians treat patients with atrial fibrillation. Two targets of pharmacologic treatment; Determination of the relative efficacy of rate control and rhythm control; Type of rate control medications.
- Considering cost implications of anticoagulants in AF. // PharmacoEconomics & Outcomes News;Nov2013, Issue 691, p6
The article offers information on the result of a study conducted by U.S. researchers which unveils the importance to consider the cost of monitoring warfarin and the consequences of suboptimal anticoagulation for stroke prophylaxis in patients with non-valvular atrial fibrillation (AF).
- Don't forget HASBLED score. Claridge, Simon B. L.; Kanaganayagam, Gajen S.; Kotecha, Tushar // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/28/2011, Vol. 342 Issue 7808, p1167
A letter to the editor is presented in response to an article on the scoring system and the new guidelines on the anticoagulation in atrial fibrilllation that was published in a previous issue.
- Genomics may change your next doctor visit. King, Pat // Las Vegas Business Press;04/02/2001, Vol. 18 Issue 14, p10
Presents news items related to the health care industry in Nevada as of April 2, 2001. University Medical Center's claims that it is the first Las Vegas hospital to give a patient a dose of Tikosyn to treat atrial fibrillation; Accreditation of PacifiCare Health Systems Inc.'s commercial and...
- How to manage warfarin therapy. Tideman, Philip A.; Tirimacco, Rosy; John, Andrew St; Roberts, Gregory W. // Australian Prescriber;Apr2015, Vol. 38 Issue 2, p44
Long-term treatment with warfarin is recommended for patients with atrial fibrillation at risk of stroke and those with recurrent venous thrombosis or prosthetic heart valves. Patient education before commencing warfarin - regarding signs and symptoms of bleeding, the impact of diet, potential...
- Counting the Cost of Atrial Fibrillation: Use of Wireless Pacemaker Technology to Innovate Care Delivery. McDaniel, Don; D'Orazio, Dan; Sutton, Brad // Modern Healthcare;4/30/2012, Vol. 42 Issue 18, special section p1
No abstract available.
- Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation. D. Wyse // Journal of Interventional Cardiac Electrophysiology;Jun2009, Vol. 25 Issue 1, p25
AbstractÂ Â This review examines pharmacotherapy of rhythm management for atrial fibrillation (AF) in the elderly. There is little research specifically focused on this topic in the elderly but five of the seven randomized controlled trials comparing pharmacologic rate control to...
- Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications. Fred Kusumoto; Karin Prussak; Melissa Wiesinger; Tammy Pullen; Cynthia Lynady // Journal of Interventional Cardiac Electrophysiology;Jun2009, Vol. 25 Issue 1, p31
Abstract IntroductionÂ Â Catheter ablation (CA) of atrial fibrillation (AF) has become a treatment option for younger patients with drug refractory AF. It is not known whether pulmonary veins (PV) have an important mechanistic role in elderly patients with AF or whether CA is an effective...